Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
|
Mar 2021
|
Leukemia
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
|
May 2012
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
|
Oct 2016
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides
|
Oct 2015
|
Leukemia
|
|
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
|
Jun 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla
|
Feb 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.
|
Feb 2017
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Expression of nucleoside metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|